“IL-17 Inhibitors and the Risk of Malignancy”, Can Dermatol Today, vol. 3, no. 1, pp. 18–21, Mar. 2022, Accessed: Sep. 17, 2026. [Online]. Available: https://canadiandermatologytoday.com/article/view/3-1-mak